Ikena Oncology, Inc. (16) | Business Operations (2)
- Form of Indemnification Agreement between the Registrant and each of its directors and executive officers (Filed With SEC on March 22, 2021)
- Master Collaboration Agreement by and between the Registrant and Celgene Corporation (now Bristol-Myers Squibb), dated January 14, 2019 (Filed With SEC on March 5, 2021)